We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Therapeutic Antibodies – News and Features

Representation of a neutrophil.

Neutrophils: Neutrophil Function, Origin and Related Conditions

In this article, we consider what neutrophils are, how they are generated, their function in the body and medical conditions related to them.
Cancer cells.

Novel Combination Therapy Shows Promise for Liver Cancer

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without compromising their safety.
Ribosome translating mRNA into a polypeptide chain.
Industry Insight

Tuning the Therapeutic Properties of tRNAs To Treat Rare Diseases

Michelle C. Werner discusses how tRNAs could transform the drug development paradigm from gene-centric to gene-agnostic and accelerate new therapies for 30 million or more patients whose genetically driven disease can be classified under Stop Codon Disease.
A network of green vessels with parts highlighted in red.

Fibrin Immunotherapy’s Potential for Treating Traumatic Brain Injury

Traumatic brain injuries come with an amplified risk for developing dementia, but a new therapeutic target and a potential immunotherapy have been identified.
Cancer cells.

Immunotherapy After Kidney Cancer Surgery Improves Overall Survival

For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.
A gloved hand pipettes liquid into a petri dish

Microbial Monitoring for Biopharma Manufacturing

Contamination is a significant issue for bioprocessing as it results in loss of time, money and effort. This article will explore the pivotal role of microbial monitoring in upholding product safety and quality standards within the biopharmaceutical industry.
Vaccine vials.

Designing a Vaccine To Block “Zombie Drug” Xylazine

Scripps Research chemical biologists have developed a vaccine to block the effects of xylazine’s toxicity. The vaccine works by training the immune system to attack the drug, which is described in a new paper published in Chemical Communications.
A collection of neurons that are tangled together.

Immunotherapy Clears Amyloid Plaques in Alzheimer’s Mouse Model

Researchers have found a different and promising way to remove the noxious amyloid plaques in Alzheimer's disease: by directly mobilizing immune cells to consume them.

Antibody Target Identified Against Crimean Congo Hemorrhagic Fever Virus

CCHFV poses a threat to U.S. military personnel and hospital staff as well as residents of a growing number of countries, says UC Riverside biomedical scientist.
An electron micrograph showing three EBV virions in red-orange.

Researchers Identify Epstein-Barr Virus’ Weak Points

Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.